Evidence map›Paper›PMID 41561102›Full record

ArticleERJ open research2026

Self-organising map clustering identifies high-risk clusters of post-acute mortality in a prospective multicentre study of community-acquired pneumonia.

Hendrik Pott, Swetlana Gaffron, Roman Martin, Dieter Maier, Max Kutzinski, Barbara Weckler, Wilhelm Bertrams, Anna Lena Jung, Katrin Laakmann, Dominik Heider and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02139163 (Epidemiological Study on Community Acquired Pneumonia), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02139163 recruitingnot on this map

Epidemiological Study on Community Acquired Pneumonia

Typeobservational_patient_registrySponsorCapnetz StiftungRan2002 to 2028Enrolled20,000ConditionsCommunity Acquired Pneumonia
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hendrik PottDepartment of Medicine, Pulmonary and Critical Care Medicine, Clinic for Airway Infections, University Medical Centre Marburg, Philipps-University Marburg, Marburg, Germany.ORCID https://orcid.org/0000-0002-6842-143X
Swetlana GaffronViscovery Software GmbH, Vienna, Austria.ORCID https://orcid.org/0000-0002-4540-0732
Roman MartinInstitute of Medical Informatics, University of Münster, Münster, Germany.ORCID https://orcid.org/0000-0001-7678-7856
Dieter MaierLabvantage-Biomax GmbH, München, Germany.
Max KutzinskiDepartment of Medicine, Pulmonary and Critical Care Medicine, Clinic for Airway Infections, University Medical Centre Marburg, Philipps-University Marburg, Marburg, Germany.
Barbara WecklerDepartment of Medicine, Pulmonary and Critical Care Medicine, Clinic for Airway Infections, University Medical Centre Marburg, Philipps-University Marburg, Marburg, Germany.
Wilhelm BertramsInstitute for Lung Research, Universities of Giessen and Marburg Lung Centre, Philipps-University Marburg, Marburg, Germany.
Anna Lena JungInstitute for Lung Research, Universities of Giessen and Marburg Lung Centre, Philipps-University Marburg, Marburg, Germany.ORCID https://orcid.org/0000-0002-7762-4597
Katrin LaakmannInstitute for Lung Research, Universities of Giessen and Marburg Lung Centre, Philipps-University Marburg, Marburg, Germany.
Dominik HeiderInstitute of Medical Informatics, University of Münster, Münster, Germany.
Claus F VogelmeierMember of the German Centre for Lung Research (DZL).
Gernot RohdeMember of the German Centre for Lung Research (DZL).ORCID https://orcid.org/0000-0002-5193-7755
CAPNETZ Study Group
Bernd SchmeckDepartment of Medicine, Pulmonary and Critical Care Medicine, Clinic for Airway Infections, University Medical Centre Marburg, Philipps-University Marburg, Marburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality. While tools predicting short-term prognosis exist, there is urgent need for the early identification of patients requiring close follow-up monitoring for post-acute mortality. We therefore conducted cluster analysis of baseline clinical data to investigate predictors of post-acute mortality in CAP. Methods: We analysed 7840 participants from the German CAPNETZ cohort, using self-organising map (SOM)-clustering and survival analyses. Random survival forest (RSF) models were used to identify key predictors of mortality, which were then analysed using time-dependent area under the curve and Cox proportional hazard regression models. Results: SOM-clustering based on 10 predictors identified 879 (12%, in four clusters) patients with high risk for post-acute (30-180 days) mortality. Across the cohort, age and urea were the most important predictors of post-acute mortality, while in the high-risk cohort, body mass index emerged as the strongest predictor, as identified by RSF modelling. In one high-risk cluster, there was an association with elevated platelet counts (HR: 1.13, 95% CI 1.03-1.21, p=0.01; increments of 40 platelets·nL Conclusion: Using 10 clinical predictors for post-acute mortality in CAP, predictive SOM-clustering revealed several high-risk subgroups, with heterogeneous biomarkers, suggestive of differences in the underlying pathophysiology (thrombocytes, urea, CRP). Adapting medical therapy to these high-risk subgroups may reduce post-acute mortality following CAP.

Identifiers

PMID41561102
PMCPMC12813681

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.